Abstract
Background: Zinc transporter (ZnT)-proteins regulate zinc fluxes into
beta-cell vesicles and recently ZnT8 was identified as a major risk factor for
developing type 2 diabetes. Contrasting other ZnTs, ZnT3 is upregulated by
high glucose levels as well as by zinc depletion in ȕ-cells. We here confirm
the glucose dependence of ZnT3 and show by electron microscopy that
ZnT3 is located in beta-cell cytoplasm. Further, we report the first results of
experiments examining glucose metabolism in ZnT3 KO mice.
Methods: Ins1-E rat beta-cells were exposed to 2, 5 or 16 mM glucose for 24
hrs. ZnT3 mRNA was measured by RT-PCR. Measurements were normalized
to a mean of three house-keeping genes. Insulin secretion was measured by
Elisa. For electron microscopy, INS1-E cells were fixed in paraformaldehyde
and examined for the presence of ZnT3 by immunogold staining with a
specific goat-rabbit antibody. To determine if knocking out the ZnT3 gene
affects whole body glucose metabolism, twelve weeks old ZnT3 KO mice
derived from the C57B16 mouse strain were compared to wild type mice after
five days of treatment with intraperitoneal streptozotocin 50mg/kg daily or
saline. After two weeks of recovery, tail blood glucose levels were measured
after a 14 hrs fast with a One Touch Ultra Meter.
Results: We confirmed that, relative to 5 mM glucose, 2 mM glucose caused
a significant down-regulation of ZnT-3 and 16 mM an up-regulation (p
< 0.01). Insulin secretion was increased at 16 mM glucose. By electron
microscopy we could identify the presence of ZnT3 in the cytoplasm of INS1-
E cells. No signifant changes in blood glucose levels were found between
ZnT3 KO- and WT mice. However, after treatment with streptozotozin, KO
mice had significantly higher blood glucose levels compared with shaminjected
KO mice (p < 0.05) and streptozotocin-treated WT mice (p < 0.01)
(Figure).
Conclusion: This study identifies ZnT3 as a pivotal regulator of beta-cell zinc
metabolism. Zinc ions have numerous roles in the islets as well as possible
roles in the periphery. These include regulation of counter-regulatory
hormones and beta-cell apoptosis as well as the formation of insulin crystals.
Originalsprog | Engelsk |
---|---|
Publikationsdato | 2013 |
Antal sider | 1 |
Status | Udgivet - 2013 |
Udgivet eksternt | Ja |
Begivenhed | 43rd EASD Annual Meeting of the European Association for the Study of Diabetes - Amsterdam, Holland Varighed: 18 jun. 2007 → 21 sep. 2007 |
Konference
Konference | 43rd EASD Annual Meeting of the European Association for the Study of Diabetes |
---|---|
Land/Område | Holland |
By | Amsterdam |
Periode | 18/06/2007 → 21/09/2007 |